XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
FINANCIAL ASSETS AND LIABILITIES (Tables)
12 Months Ended
Mar. 31, 2024
FINANCIAL ASSETS AND LIABILITIES  
Financial assets and financial liabilities measured at fair value on a recurring basis

Fair Value

Hierarchy

At March 31, 2024

At March 31, 2023

(Dollars in millions)

    

Level

    

Assets

    

Liabilities

    

Fair Value

    

Assets

    

Liabilities

    

Fair Value

Derivatives designated as hedging instruments:

Foreign exchange contracts

2

$

2

$

1

$

1

$

4

$

3

$

1

Cross-currency swap contracts

2

1

11

(9)

Derivatives not designated as hedging instruments:

Foreign exchange contracts

2

2

6

(4)

11

5

6

Total

$

5

$

18

$

(13)

$

15

$

9

$

6

Summary of notional amounts of outstanding derivatives

At March 31, 2024

At March 31, 2023

(Dollars in millions)

Foreign Exchange Contracts

    

Cross-currency Swap Contracts

Foreign Exchange Contracts

    

Cross-currency Swap Contracts

Derivatives designated as hedging instruments

Cash flow hedges

$

281

$

$

283

$

Net investment hedges

500

Derivatives not designated as hedging instruments

$

1,624

$

$

1,506

$

Effect of derivative instruments in the Consolidated Income Statement - designated

Gain (Loss) Recognized in Consolidated Income Statement

and Other Comprehensive Income

Three

Year Ended

Year Ended

Months Ended

Year Ended

March 31,

March 31,

March 31,

December 31,

(Dollars in millions)

    

2024

    

2023

    

2022

2021

Derivative instruments in cash flow hedges:

Recognized in OCI *

Foreign exchange contracts

22

(4)

1

4

Derivative instruments in net investment hedges:

Cross-currency swaps **

(11)

Total

$

11

$

(4)

$

1

$

4

Consolidated Income Statement line item

Reclassified from AOCI *

Cost of services

21

(2)

1

1

Interest expenses **

1

Total

$

23

$

(2)

$

1

$

1

*Pre-Separation, the effects of hedging activity were allocated from the former Parent directly to the Company’s Consolidated Income Statement, resulting in no gain (loss) either recognized in other comprehensive income or reclassified from accumulated other comprehensive income.

**

For the year ended March 31, 2024, the Company recognized a gain of $1 million in interest expense on components excluded from the assessment of the hedge effectiveness for net investment hedges. There were no net investment hedges in the year ended March 31, 2023, the three months ended March 31, 2022 and the year ended December 31, 2021.

Effect of derivative instruments in the Consolidated Income Statement- Not designated

Gain (Loss) Recognized in Consolidated Income Statement

Three

Consolidated

Year Ended

Year Ended

Months Ended

Year Ended

Income Statement

March 31,

March 31,

March 31,

December 31,

(Dollars in millions)

    

Line Item

2024

2023

2022

2021

Derivative instruments not designated as hedging instruments:

Foreign exchange contracts

Other expense

(48)

20

(1)

4

Total

  

$

(48)

$

20

$

(1)

$

4